Disc Medicine (IRON) Competitors $72.46 +0.50 (+0.69%) As of 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRON vs. VRNA, RVMD, RGC, MRUS, RNA, GRFS, CYTK, RYTM, ABVX, and CRSPShould you be buying Disc Medicine stock or one of its competitors? The main competitors of Disc Medicine include Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Regencell Bioscience (RGC), Merus (MRUS), Avidity Biosciences (RNA), Grifols (GRFS), Cytokinetics (CYTK), Rhythm Pharmaceuticals (RYTM), Abivax (ABVX), and CRISPR Therapeutics (CRSP). These companies are all part of the "pharmaceutical products" industry. Disc Medicine vs. Its Competitors Verona Pharma PLC American Depositary Share Revolution Medicines Regencell Bioscience Merus Avidity Biosciences Grifols Cytokinetics Rhythm Pharmaceuticals Abivax CRISPR Therapeutics Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) and Disc Medicine (NASDAQ:IRON) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends. Does the media favor VRNA or IRON? In the previous week, Disc Medicine had 1 more articles in the media than Verona Pharma PLC American Depositary Share. MarketBeat recorded 10 mentions for Disc Medicine and 9 mentions for Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.13 beat Disc Medicine's score of 0.49 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Verona Pharma PLC American Depositary Share 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Disc Medicine 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is VRNA or IRON more profitable? Disc Medicine has a net margin of 0.00% compared to Verona Pharma PLC American Depositary Share's net margin of -36.62%. Verona Pharma PLC American Depositary Share's return on equity of -21.12% beat Disc Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Verona Pharma PLC American Depositary Share-36.62% -21.12% -9.07% Disc Medicine N/A -26.60%-24.58% Which has preferable valuation & earnings, VRNA or IRON? Disc Medicine has lower revenue, but higher earnings than Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share is trading at a lower price-to-earnings ratio than Disc Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVerona Pharma PLC American Depositary Share$42.28M217.94-$173.42M-$0.99-107.99Disc MedicineN/AN/A-$109.36M-$4.47-16.21 Do analysts rate VRNA or IRON? Verona Pharma PLC American Depositary Share presently has a consensus price target of $109.00, indicating a potential upside of 1.95%. Disc Medicine has a consensus price target of $98.30, indicating a potential upside of 35.66%. Given Disc Medicine's stronger consensus rating and higher probable upside, analysts plainly believe Disc Medicine is more favorable than Verona Pharma PLC American Depositary Share.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Verona Pharma PLC American Depositary Share 1 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.07Disc Medicine 1 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.92 Do insiders and institutionals believe in VRNA or IRON? 85.9% of Verona Pharma PLC American Depositary Share shares are owned by institutional investors. Comparatively, 83.7% of Disc Medicine shares are owned by institutional investors. 4.8% of Verona Pharma PLC American Depositary Share shares are owned by insiders. Comparatively, 3.6% of Disc Medicine shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, VRNA or IRON? Verona Pharma PLC American Depositary Share has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500. Comparatively, Disc Medicine has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. SummaryDisc Medicine beats Verona Pharma PLC American Depositary Share on 9 of the 16 factors compared between the two stocks. Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRON vs. The Competition Export to ExcelMetricDisc MedicineMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.53B$3.37B$6.05B$10.51BDividend YieldN/A2.31%5.73%4.82%P/E Ratio-16.2622.2185.5327.36Price / SalesN/A472.84592.56135.63Price / CashN/A44.9825.7730.18Price / Book4.8810.4612.696.79Net Income-$109.36M-$52.58M$3.32B$276.59M7 Day Performance6.73%1.15%0.58%1.08%1 Month Performance21.13%14.95%9.50%8.50%1 Year Performance50.99%21.65%79.27%44.54% Disc Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRONDisc Medicine2.4277 of 5 stars$72.46+0.7%$98.30+35.7%+50.7%$2.53BN/A-16.2630VRNAVerona Pharma PLC American Depositary Share1.4394 of 5 stars$106.91+0.1%$109.00+2.0%N/A$8.75B$221.67M-107.9930Positive NewsRVMDRevolution Medicines4.0834 of 5 stars$46.58-0.3%$74.64+60.2%-3.4%$8.71BN/A-10.35250RGCRegencell Bioscience0.4223 of 5 stars$17.25+0.9%N/AN/A$8.53BN/A0.0010Positive NewsMRUSMerus0.9058 of 5 stars$94.270.0%$93.12-1.2%+77.6%$7.13B$56.23M-17.1437RNAAvidity Biosciences1.9756 of 5 stars$46.18-1.7%$68.32+47.9%+5.1%$6.86B$10.90M-12.97190Gap DownGRFSGrifols3.7355 of 5 stars$9.61-3.4%$10.30+7.2%+10.0%$6.84B$7.81B8.2123,822Analyst DowngradeCYTKCytokinetics3.6747 of 5 stars$60.64+6.4%$76.64+26.4%+8.6%$6.82B$18.47M-11.89250RYTMRhythm Pharmaceuticals3.0848 of 5 stars$97.86-1.2%$106.64+9.0%+102.3%$6.58B$156.29M-32.51140Positive NewsABVXAbivax2.6772 of 5 stars$86.67+3.3%$103.29+19.2%+904.5%$6.34BN/A0.0061Analyst ForecastHigh Trading VolumeCRSPCRISPR Therapeutics1.6567 of 5 stars$70.19+3.6%$71.50+1.9%+45.8%$6.16B$35M-12.93460Analyst Forecast Related Companies and Tools Related Companies Verona Pharma PLC American Depositary Share Alternatives Revolution Medicines Alternatives Regencell Bioscience Alternatives Merus Alternatives Avidity Biosciences Alternatives Grifols Alternatives Cytokinetics Alternatives Rhythm Pharmaceuticals Alternatives Abivax Alternatives CRISPR Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRON) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
